Jad Chahoud, Chief Scientific and Innovation Officer at Orlando Health Cancer Institute, shared a post on LinkedIn:
“Excited to welcome Dr. Fawzi Abu Rous to OHCI Orlando Health Grand Rounds this Monday, April 6 at 5:30 PM at ORMC MPRs.
A leader in early therapeutics and thoracic oncology, Dr. Abu Rous Henry Ford Health will share insights on ‘Drug Development: From First-In-Human to FDA Approval’ a timely and powerful look at how innovative cancer therapies move from concept to clinical impact.”
Other Articles Featuring Jad Chahoud on OncoDaily.